美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0406-0807-01	0406-0807	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single-Entity Amphetamine Product	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20231101	N/A	ANDA	ANDA211546	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	9.375 mg/1; 9.375 mg/1; 9.375 mg/1; 9.375 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-0807-01)
0406-0803-01	0406-0803	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single-Entity Amphetamine Product	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20231101	N/A	ANDA	ANDA211546	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25 mg/1; 6.25 mg/1; 6.25 mg/1; 6.25 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-0803-01)
0406-0804-01	0406-0804	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single-Entity Amphetamine Product	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20231101	N/A	ANDA	ANDA211546	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	12.5 mg/1; 12.5 mg/1; 12.5 mg/1; 12.5 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-0804-01)
0406-0805-01	0406-0805	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single-Entity Amphetamine Product	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20231101	N/A	ANDA	ANDA211546	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125 mg/1; 3.125 mg/1; 3.125 mg/1; 3.125 mg/1	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-0805-01)